Sessile serrated lesion detection rates during average risk screening colonoscopy: A systematic review and meta-analysis of the published literature
- PMID: 33869735
- PMCID: PMC8043815
- DOI: 10.1055/a-1352-4095
Sessile serrated lesion detection rates during average risk screening colonoscopy: A systematic review and meta-analysis of the published literature
Abstract
Background and study aims Sessile serrated lesion (SSL) detection rate has been variably reported and unlike adenoma detection rate (ADR) is not currently a quality indicator for screening colonoscopy. Composite detection rates of SSL in patients undergoing average risk screening colonoscopy are not available. Methods Electronic database search (Medline, Embase and Cochrane) was conducted for studies reporting detection rates of serrated polyps (SSL, Hyperplastic polyp, traditional serrated adenoma) among average risk subjects undergoing screening colonoscopy. Primary outcomes were pooled SDR (SSL detection rate) and proximal serrated polyp detection rate (PSPDR). Pooled proportion rates were calculated with 95 %CI with assessment of heterogeneity (I 2 ). Publication bias, regression test and 95 %prediction interval were calculated. Results A total of 280,370 screening colonoscopies among average risk subjects that were eligible with 48.9 % males and an average age of 58.7 years (± 3.2). The pooled SDR was available from 16 studies: 2.5 % (1.8 %-3.4 %) with significant heterogeneity (I 2 = 98.66 %) and the 95 % prediction interval ranging from 0.6 % to 9.89 %. When analysis was restricted to large (n > 1000) and prospective studies (n = 4), SDR was 2 % (1.1 %-3.3 %). Pooled PSPDR was 10 % (8.5 %-11.8 %; 12 studies). There was evidence of publication bias ( P < 0.01). Conclusion Definitions of SSL have been varying over years and there exists significant heterogeneity in prevalence reporting of serrated polyps during screening colonoscopy. Prevalence rate of 2 % for SSL and 10 % for proximal serrated polyps could serve as targets while robust high-quality data is awaited to find a future benchmark showing reduction in colorectal cancer arising from serrated pathway.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Conflict of interest statement
Competing interests The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Simple proxies for detection of clinically significant serrated polyps and data for their benchmarks.J Gastroenterol Hepatol. 2020 Aug;35(8):1365-1371. doi: 10.1111/jgh.14977. Epub 2020 Jan 21. J Gastroenterol Hepatol. 2020. PMID: 31907971
-
Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry.Gastrointest Endosc. 2017 Jun;85(6):1188-1194. doi: 10.1016/j.gie.2017.01.020. Epub 2017 Jan 31. Gastrointest Endosc. 2017. PMID: 28153571 Free PMC article.
-
Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of center.Clin Gastroenterol Hepatol. 2014 Jul;12(7):1119-26. doi: 10.1016/j.cgh.2013.11.034. Epub 2013 Dec 10. Clin Gastroenterol Hepatol. 2014. PMID: 24333512
-
Adenomas and Sessile Serrated Lesions in 45- to 49-Year-Old Individuals Undergoing Colonoscopy: A Systematic Review and Meta-Analysis.Am J Gastroenterol. 2024 Aug 1;119(8):1600-1606. doi: 10.14309/ajg.0000000000002735. Epub 2024 Feb 29. Am J Gastroenterol. 2024. PMID: 38421004
-
Colorectal Cancer Screening for the Serrated Pathway.Gastrointest Endosc Clin N Am. 2020 Jul;30(3):457-478. doi: 10.1016/j.giec.2020.02.007. Epub 2020 Apr 8. Gastrointest Endosc Clin N Am. 2020. PMID: 32439082 Review.
Cited by
-
Impact of AI-aided colonoscopy in clinical practice: a prospective randomised controlled trial.BMJ Open Gastroenterol. 2024 Jan 30;11(1):e001247. doi: 10.1136/bmjgast-2023-001247. BMJ Open Gastroenterol. 2024. PMID: 38290758 Free PMC article. Clinical Trial.
-
Colonoscopy findings in CDH1 carriers from a multicenter international study.Fam Cancer. 2025 May 5;24(2):44. doi: 10.1007/s10689-025-00466-8. Fam Cancer. 2025. PMID: 40323501 Free PMC article.
-
Sessile serrated lesion detection rates continue to increase: 2008-2020.Endosc Int Open. 2023 Jan 26;11(1):E107-E116. doi: 10.1055/a-1990-0509. eCollection 2023 Jan. Endosc Int Open. 2023. PMID: 36712908 Free PMC article.
-
Real-time artificial intelligence (AI)-aided endoscopy improves adenoma detection rates even in experienced endoscopists: a cohort study in Singapore.Surg Endosc. 2023 Jan;37(1):165-171. doi: 10.1007/s00464-022-09470-w. Epub 2022 Jul 26. Surg Endosc. 2023. PMID: 35882667 Free PMC article.
-
Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT-based CRC screening program.Int J Cancer. 2023 Apr 15;152(8):1536-1546. doi: 10.1002/ijc.34373. Epub 2022 Dec 1. Int J Cancer. 2023. PMID: 36444504 Free PMC article.
References
-
- Siegel R L, Miller K D, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29. - PubMed
-
- Rex D K, Petrini J L, Baron T H et al.Quality indicators for colonoscopy. Am J Gastroenterol. 2006;101:873–885. - PubMed
-
- Kaminski M F, Wieszczy P, Rupinski M et al.Increased rate of adenoma detection associates with reduced risk of colorectal cancer and death. Gastroenterology. 2017;153:98–105. - PubMed
-
- Hassan C, Repici A. Defeating cancer by boosting the adenoma detection rate: the circle of life. Gastroenterology. 2017;153:8–10. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous